TTP Group continues to grow

 

©UCB Farchim SA, Bulle Switzerland

 

©UCB Farchim SA, Bulle Switzerland

TTP Group operates with Triplan in four countries

„The”TTP Group’s Europe-wide growth strategy is reflected in a further strengthening of its market presence throughout the DACH region,”, says Andreas Bonhoff, CEO TTP Group.

Both Triplan and Pharmaplan are hereby expanding their already close cooperation with customers in these two important chemical and pharmaceutical locations.

With the newly founded Triplan AT GmbH, the TTP Group is now also present in Linz since February 1, 2021. Linz is considered the capital of the leading industrial, export and technology state of Upper Austria .
This means that the TTP Group with Triplan is now active in four countries. In Germany, in Switzerland, in India and now also in Austria. Here, Triplan offers engineering services for the chemical and petrochemical industries.
Triplan Managing Director Peter Stromberger emphasizes the importance of the new location in terms of proximity to his local customers:
“Linz is the logical continuation of Triplan’s proven business model, namely operational planning, which includes the entire portfolio consisting of operational engineering, the handling of EPCm projects and consulting services for the chemical and petrochemical industry”.

New Pharmaplan site in Entzheim, France

Another site has been opened by TTP’s French subsidiary Pharmaplan S.A. in February in Entzheim, France. For Arnaud Eber, Pharmaplan’s managing director in France and Belgium, the new location is in line with the group’s philosophy of proximity to customers and partners:
“With the two Pharmaplan sites in Entzheim and Lyon, we are now closer to the pharmaceutical and biotech players in the Grand Est region, one of the most important areas in France for pharmaceutical and biotech production. This will allow us to strengthen existing collaborations with some key customers in the region, such as Lilly, Octapharma and Novartis, but also to develop new partnerships with other pharmaceutical and biotech companies in the Alsace cluster.”

Altogether, Pharmaplan’s four French sites in Paris, Lyon, Chartres and Entzheim cover Pharmaplan’s entire service portfolio: Front-end studies, general planning (EPCMV), site projects and premium consulting in GMP, quality, process, cleanroom, automation and digitalization. Further Pharmaplan site openings are planned in Switzerland. As one of the leading pharmaceutical engineering companies in Europe, Pharmaplan is shaping the future of the industry. With the planning and construction of modern pharmaceutical production sites, excellent employees from the fields of architecture, engineering and natural sciences are setting the course for the global drug supply of tomorrow.
[/vc_column_text][/vc_column][/vc_row]